Loading organizations...
§ Private Profile · San Francisco, CA, USA
Medtech company developing a sensor-enabled digital platform for real-time fluid analytics and remote monitoring in peritoneal dialysis.
Based in San Francisco, California, CloudCath develops a sensor-enabled digital platform that utilizes machine learning and Internet of Things technology for real-time fluid analytics and remote patient monitoring in peritoneal dialysis. The medical device company provides hardware and software solutions to nephrologists, dialysis providers, and healthcare organizations to detect complications such as infections early in at-home patients. The enterprise operates with a team of at least eight full-time employees and secured $12 million in Series A venture capital funding in 2020 to accelerate the commercialization of its monitoring technology. CloudCath has participated in the MedTech Innovator cohort and is guided by notable medical professionals, including Chief Medical Officer Don Williamson and Stanford University Chief of Nephrology Glenn Chertow, who chairs its clinical advisory board. The company was founded in 2017 by Aly ElBadry and Eric Yu.
CloudCath has raised $12.0M across 1 funding round.
CloudCath has raised $12.0M in total across 1 funding round.
CloudCath has raised $12.0M in total across 1 funding round.
CloudCath's investors include Capital Integral, FundRx, Glenn Chertow, The Capital Partnership.
CloudCath has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series A in February 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 13, 2020 | $12M Series A | Capital Integral | FundRx, Glenn Chertow, The Capital Partnership | Announced |